These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37186667)

  • 21. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.
    Zou Y; Lan J; Zhong Y; Yang S; Zhang H; Xie G
    Lipids Health Dis; 2021 Oct; 20(1):139. PubMed ID: 34657611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertriglyceridemic hyperapoB and the development and resolution of nonalcoholic fatty liver disease: a cohort study.
    Wang Y; Kong L; Ye C; Dou C; Li M; Zhao Z; Xu Y; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T
    J Lipid Res; 2023 Aug; 64(8):100418. PubMed ID: 37481036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High remnant-cholesterol levels increase the risk for end-stage renal disease: a nationwide, population-based, cohort study.
    Jung HN; Huh JH; Roh E; Han KD; Kang JG; Lee SJ; Ihm SH
    Lipids Health Dis; 2024 Jun; 23(1):165. PubMed ID: 38835081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study.
    Lee JH; Kim J; Kim JO; Kwon YJ
    J Transl Med; 2023 Jul; 21(1):435. PubMed ID: 37403158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement.
    Zhu Z; Yang N; Fu H; Yuan G; Chen Y; Du T; Zhou X
    Front Endocrinol (Lausanne); 2022; 13():1002099. PubMed ID: 36187115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease.
    Du T; Sun X; Yu X
    Lipids Health Dis; 2017 Dec; 16(1):229. PubMed ID: 29197406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.
    Dowla S; Aslibekyan S; Goss A; Fontaine K; Ashraf AP
    J Clin Lipidol; 2018; 12(4):981-987. PubMed ID: 29699915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.
    Fan N; Peng L; Xia Z; Zhang L; Song Z; Wang Y; Peng Y
    Lipids Health Dis; 2019 Feb; 18(1):39. PubMed ID: 30711017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level.
    Lee JH; Lee HS; Cho AR; Lee YJ; Kwon YJ
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33810315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease Risk among Chinese Adults.
    Zhao H; Qiu X; Li HZ; Cui JJ; Sun YY
    Biomed Environ Sci; 2023 Jan; 36(1):1-9. PubMed ID: 36650677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study.
    Miao Y; Tao H
    BMJ Open; 2023 May; 13(5):e069440. PubMed ID: 37147088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study.
    Wang K; Shan S; Zheng H; Zhao X; Chen C; Liu C
    Lipids Health Dis; 2018 Aug; 17(1):196. PubMed ID: 30131058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population.
    Shi L; Zhang D; Ju J; Wang A; Du T; Chen X; Song Y; Gao Z; Xu H
    Front Endocrinol (Lausanne); 2023; 14():1260764. PubMed ID: 37842298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.
    Fu L; Tai S; Sun J; Zhang N; Zhou Y; Xing Z; Wang Y; Zhou S
    Diabetes Care; 2022 Sep; 45(9):2136-2143. PubMed ID: 35834242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.
    Wang X; Han Y; Liu Y; Hu H
    BMC Gastroenterol; 2022 Sep; 22(1):419. PubMed ID: 36104672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
    Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.